Medical device company Protembis GmbH wins state subsidy programme “KMU-innovativ: Medizintechnik”
Medical device company Protembis GmbH wins state subsidy programme “KMU-innovativ: Medizintechnik”. Granted by the Federal Ministry of Education and Research (BMBF), the programme supports innovative small and medium-sized enterprises
Hamburg, Germany, April 24, 2015
Hamburg-based startup company Protembis GmbH has secured a seven-digit state subsidy programme in cooperation with the Institute for Cardiovascular Engineering at RWTH University, Aachen, which is granted by the Federal Ministry of Education and Research. Protembis aims to develop, manufacture and commercialise an embolic protection device to be used during left heart procedures and vascular interventions. The ProtEmbo® device is intended to protect patients from the risk of suffering a stroke during these procedures. The Federal Ministry of Education and Research offers the “KMU-innovativ” funding programme to promote cutting-edge research and development projects and to foster small and medium-sized enterprise innovation in Germany. Protembis was among the very few companies to be accepted for the subsidy programme and will use the funding for research and development on its ProtEmbo® device.
Founded in autumn 2013, Protembis is a medical device start-up company headquartered in the vibrant Betahaus Hamburg, with an R&D base in the medical technology city of Aachen. The team’s vision is to bring its protection device into every interventional and surgical heart procedure, reducing the number of strokes and radically improving patient safety.
Conrad Rasmus & Karl von Mangoldt
Co-CEOs & Co-Founders
+49(0)241 9903 3622